Viewing data from:

MORPHINE SULFATE

ANDA

MORPHINE SULFATE | A202348 | SPECGX LLC

1 strength0 unique patents0 unique exclusivities

Reference Listed Drug: MORPHINE SULFATE(TE code: AA)

Drug Pricing (NADAC)

National Average Drug Acquisition Cost — Week of 2026-07-15 | 3 NDCs

Highest NADAC/Unit

$0.4847

per ml

Lowest NADAC/Unit

$0.3280

per ml

Brand NDCs

Generic NDCs

NDC Description	NADAC/Unit	Unit	Type	Generic NADAC	Effective
00406800315MORPHINE SULF 100 MG/5 ML CONC	$0.4847	ML	Generic	—	2026-06-17
00406800330MORPHINE SULF 100 MG/5 ML CONC	$0.4185	ML	Generic	—	2026-06-17
00406800312MORPHINE SULF 100 MG/5 ML CONC	$0.3280	ML	Generic	—	2026-06-17

Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.

VA Federal Supply Schedule

Government-negotiated contract prices | 3 NDCs (3 FSS)

Lowest Price

$6.52

Highest Price

$60.77

FSS NDCs

Big4 NDCs

Description	Price	Type	Vendor	Contract End
00406-8003-12MORPHINE CONCENTRATED 20MG/ML SOLN,ORAL	$60.77	FSS	SpecGx LLC	09/14/2027
00406-8003-15MORPHINE CONCENTRATED 20MG/ML SOLN,ORAL	$7.83	FSS	SpecGx LLC	09/14/2027
00406-8003-30MORPHINE SO4 20MG/ML SOLN,CONC,ORAL	$6.52	FSS	SpecGx LLC	09/14/2027

Source: VA Federal Supply Schedule (va.gov). Prices are government-negotiated contract prices.

API Supply Chain4 active DMFs6 inactive

3 active API suppliers hold Drug Master Files for this ingredient.

SPECGX LLCMORPHINE SULFATE

DMF 58571985

NORAMCO LLCMORPHINE SULFATE

DMF 69671987

VERANOVA LPMORPHINE SULFATE USP

DMF 215882008

NORAMCO LLCMORPHINE SULFATE, USP

DMF 293172015

PENICK CORPInactiveMORPHINE SULFATE

DMF 66801986

MACFARLAN SMITH LTDInactiveMORPHINE SULFATE

DMF 83281989

MALLINCKRODT INCInactiveMORPHINE SULFATE INJECTION USP

DMF 115291995

ELAN PHARMA LTDInactiveMORPHINE SULFATE

DMF 128081997

SIEGFRIED USA LLCInactiveMORPHINE SULFATE USP

DMF 196932006

CODY LABORATORIES INCInactiveMORPHINE SULFATE, USP

DMF 280402014

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (1)

#001 — 100MG/5ML

0 patents0 exclusivities▴

SOLUTION;ORAL | Approved: Jul 15, 2011

No patent or exclusivity listings for this strength.